EA200100278A1 - Способы модулирования киназных белков множественных линий и скрининга соединений, которые модулируют киназные белки множественных линий - Google Patents
Способы модулирования киназных белков множественных линий и скрининга соединений, которые модулируют киназные белки множественных линийInfo
- Publication number
- EA200100278A1 EA200100278A1 EA200100278A EA200100278A EA200100278A1 EA 200100278 A1 EA200100278 A1 EA 200100278A1 EA 200100278 A EA200100278 A EA 200100278A EA 200100278 A EA200100278 A EA 200100278A EA 200100278 A1 EA200100278 A1 EA 200100278A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- multiple lines
- kinase proteins
- protein
- modulate
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title abstract 6
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 102000020233 phosphotransferase Human genes 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 5
- 238000012216 screening Methods 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 230000004770 neurodegeneration Effects 0.000 abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000004083 survival effect Effects 0.000 abstract 2
- 230000030833 cell death Effects 0.000 abstract 1
- 230000004952 protein activity Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
Abstract
Предоставлены способы идентификации соединений, которые модулируют активность киназного белка множественных линий и повышают выживаемость клеток или гибель клеток, включающие в себя этапы контактирования клетки, содержащей киназный белок множественных линий с соединением, определения того, снижает ли соединение активность киназного белка множественных линий, и определения того, повышает ли соединение выживаемость клеток. Также представлены способы идентификации соединений, которые могут быть пригодны при лечении нейродегенеративных заболеваний и/или воспаления. Также предоставлены способы модулирования активности киназного белка множественных линий, включающие в себя контактирование белка или клетки, содержащей белок, с индено- или индолосоединением согласно изобретению. Также предоставлены способы лечения нейродегенеративных заболеваний и/или воспаления.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9798098P | 1998-08-26 | 1998-08-26 | |
PCT/US1999/018864 WO2000013015A1 (en) | 1998-08-26 | 1999-08-18 | Modulating multiple lineage kinase proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200100278A1 true EA200100278A1 (ru) | 2002-06-27 |
EA006648B1 EA006648B1 (ru) | 2006-02-24 |
Family
ID=22266038
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200500934A EA200500934A1 (ru) | 1998-08-26 | 1999-08-18 | Соединения, модулирующие активность киназного белка множественных линий, и способы лечения нейродегенеративных и воспалительных заболеваний |
EA200100278A EA006648B1 (ru) | 1998-08-26 | 1999-08-18 | Способы модулирования киназных белков множественных линий и скрининга соединений, которые модулируют киназные белки множественных линий |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200500934A EA200500934A1 (ru) | 1998-08-26 | 1999-08-18 | Соединения, модулирующие активность киназного белка множественных линий, и способы лечения нейродегенеративных и воспалительных заболеваний |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1105728B1 (ru) |
JP (1) | JP2002523780A (ru) |
KR (1) | KR100700028B1 (ru) |
CN (3) | CN1206535C (ru) |
AT (1) | ATE293254T1 (ru) |
AU (1) | AU765637B2 (ru) |
BG (1) | BG105360A (ru) |
BR (1) | BR9913190A (ru) |
CA (1) | CA2339539A1 (ru) |
CZ (1) | CZ2001701A3 (ru) |
DE (1) | DE69924738T2 (ru) |
DK (1) | DK1105728T3 (ru) |
EA (2) | EA200500934A1 (ru) |
ES (1) | ES2241316T3 (ru) |
HK (1) | HK1037722A1 (ru) |
HU (1) | HUP0103079A3 (ru) |
NO (1) | NO20010389L (ru) |
NZ (1) | NZ509612A (ru) |
PL (1) | PL346246A1 (ru) |
PT (1) | PT1105728E (ru) |
SK (1) | SK2542001A3 (ru) |
TR (2) | TR200400635T2 (ru) |
UA (1) | UA74772C2 (ru) |
WO (1) | WO2000013015A1 (ru) |
ZA (1) | ZA200100835B (ru) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811992B1 (en) | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
US6841567B1 (en) | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
US7122679B2 (en) * | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
CZ2003680A3 (cs) * | 2000-08-11 | 2003-11-12 | Cephalon, Inc. | Způsob modulace kinasových proteinů s vícenásobnou vazbou a vyhledávání sloučenin modulujících kinasové proteiny s vícenásobnou vazbou |
US7018999B2 (en) | 2001-05-16 | 2006-03-28 | Cephalon, Inc. | Methods for the treatment and prevention of pain |
FR2826653B1 (fr) * | 2001-06-29 | 2005-10-14 | Servier Lab | Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP2003052395A (ja) * | 2001-08-09 | 2003-02-25 | Japan Tissue Engineering:Kk | 移植適正判定方法 |
AR069501A1 (es) | 2007-11-30 | 2010-01-27 | Genentech Inc | Anticuerpos anti- vegf (factor de crecimiento endotelial vascular) |
JP2011517339A (ja) * | 2008-02-04 | 2011-06-02 | ガラパゴス・ナムローゼ・フェンノートシャップ | 神経変性疾患の治療に有用な分子標的及び化合物並びにこれらの同定方法 |
US20100056609A1 (en) * | 2008-08-26 | 2010-03-04 | Washington University | Methods and compositions for inhibition of axonal degeneration by modulation of the dlk/jnk pathway |
AU2015202365B2 (en) * | 2008-10-22 | 2016-11-24 | Genentech, Inc. | Modulation of axon degeneration |
US9101645B2 (en) | 2008-10-22 | 2015-08-11 | Genentech, Inc. | Modulation of axon degeneration |
MX2012004638A (es) * | 2009-10-22 | 2012-07-04 | Genentech Inc | Modulacion de degeneracion de axones. |
ES2385157B1 (es) * | 2010-02-25 | 2013-07-08 | Universidad Del País Vasco | Compuestos para el tratamiento de alzheimer. |
EP2852388A4 (en) | 2012-05-23 | 2016-01-13 | Univ Johns Hopkins | COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
CN109060472A (zh) * | 2018-07-20 | 2018-12-21 | 上海市农业科学院 | 一种适于荧光染色的草菇菌褶组织切片的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756494A (en) * | 1992-07-24 | 1998-05-26 | Cephalon, Inc. | Protein kinase inhibitors for treatment of neurological disorders |
US5475110A (en) * | 1994-10-14 | 1995-12-12 | Cephalon, Inc. | Fused Pyrrolocarbazoles |
US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US6811992B1 (en) * | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
-
1999
- 1999-08-18 HU HU0103079A patent/HUP0103079A3/hu unknown
- 1999-08-18 TR TR2004/00635T patent/TR200400635T2/xx unknown
- 1999-08-18 SK SK254-2001A patent/SK2542001A3/sk unknown
- 1999-08-18 DE DE69924738T patent/DE69924738T2/de not_active Expired - Lifetime
- 1999-08-18 AT AT99943759T patent/ATE293254T1/de active
- 1999-08-18 KR KR1020017002385A patent/KR100700028B1/ko active IP Right Grant
- 1999-08-18 ES ES99943759T patent/ES2241316T3/es not_active Expired - Lifetime
- 1999-08-18 BR BR9913190-0A patent/BR9913190A/pt not_active Application Discontinuation
- 1999-08-18 EA EA200500934A patent/EA200500934A1/ru unknown
- 1999-08-18 PL PL99346246A patent/PL346246A1/xx not_active Application Discontinuation
- 1999-08-18 TR TR2001/00589T patent/TR200100589T2/xx unknown
- 1999-08-18 DK DK99943759T patent/DK1105728T3/da active
- 1999-08-18 CA CA002339539A patent/CA2339539A1/en not_active Abandoned
- 1999-08-18 WO PCT/US1999/018864 patent/WO2000013015A1/en active IP Right Grant
- 1999-08-18 JP JP2000567949A patent/JP2002523780A/ja active Pending
- 1999-08-18 EA EA200100278A patent/EA006648B1/ru not_active IP Right Cessation
- 1999-08-18 NZ NZ509612A patent/NZ509612A/en not_active IP Right Cessation
- 1999-08-18 CN CNB998101354A patent/CN1206535C/zh not_active Expired - Fee Related
- 1999-08-18 CZ CZ2001701A patent/CZ2001701A3/cs unknown
- 1999-08-18 AU AU56793/99A patent/AU765637B2/en not_active Ceased
- 1999-08-18 EP EP99943759A patent/EP1105728B1/en not_active Expired - Lifetime
- 1999-08-18 CN CNA2004100491086A patent/CN1589788A/zh active Pending
- 1999-08-18 UA UA2001031963A patent/UA74772C2/uk unknown
- 1999-08-18 PT PT99943759T patent/PT1105728E/pt unknown
- 1999-08-18 CN CNA200610099703XA patent/CN1879617A/zh active Pending
-
2001
- 2001-01-23 NO NO20010389A patent/NO20010389L/no not_active Application Discontinuation
- 2001-01-30 ZA ZA2001/00835A patent/ZA200100835B/en unknown
- 2001-03-19 BG BG105360A patent/BG105360A/bg unknown
- 2001-11-23 HK HK01108292A patent/HK1037722A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200100278A1 (ru) | Способы модулирования киназных белков множественных линий и скрининга соединений, которые модулируют киназные белки множественных линий | |
EA199900381A1 (ru) | Арил(тио)эфиры галогенпиримидина в качестве пестицидов | |
EA199900559A1 (ru) | Замещенные, азотсодержащие гетероциклы в качестве ингибиторов протеинкиназы p38 | |
EA200201183A1 (ru) | Новые полициклические соединения и их применение | |
EA200000109A1 (ru) | Химерный белок растворимого рецептора интерлейкина-6/лиганда, его аналоги и способы применения | |
DE69816109D1 (de) | Substituierte imidazole zur behandlung von entzündlichen krankheiten | |
HK1027112A1 (en) | Survivin, a protein that inhibits cellular apoptosis, and its modulation | |
EA199900808A1 (ru) | Бифенилсульфонамиды и их производные, модулирующие активность эндотелина | |
EA199900758A1 (ru) | Малые молекулы, полезные при лечении воспалительных заболеваний | |
EA200000868A1 (ru) | Ингибиторы фосфолипаз | |
EA199700359A1 (ru) | Пептиды и соединения, связывающиеся с тромбопоэтиновым рецептором | |
EA199900620A1 (ru) | Фталазиноны | |
EA200500856A1 (ru) | Новые химические соединения | |
DE69739245D1 (de) | System zur Identifizierung von Material mittels NIR-Spektrometrie | |
NZ323795A (en) | Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides | |
EA199900421A1 (ru) | Бензонафтиридины в качестве бронхиальных терапевтических средств | |
DE69630955T2 (de) | Immortalisierung bzw. desimmortalisierung von zellen | |
WO1999025878A3 (en) | Methods for modulating and identifying cellular senescence | |
EA199800867A1 (ru) | Соединения тетрагидробетакарболина | |
ATE499445T1 (de) | Menschliche ubiqutin ligase e3. verwendung für die modulation von nf-kappa b | |
AU2002248180A1 (en) | Non-apoptotic forms of cell death and methods of modulation | |
WO2002005843A3 (en) | Human rrp sequences and methods of use | |
WO2002014536A3 (en) | Odulating multiple lineage kinase proteins | |
EA200100049A1 (ru) | Способы снижения уровней гомоцистеина и c-реактивного белка | |
DE69734890D1 (de) | Rdgb-proteine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |